Advertisement

Oncology

Twenty percent of  patients who received chimeric antigen receptor T-cell therapy experienced adverse cardiovascular and pulmonary events, a study published in the November issue of Journal of the American College of Cardiology found. 

These six oncologists joined new practices or received new appointments over the last few months. 

Advertisement

Tasneem Bawa-Khalfe, PhD, assistant professor of biology and biochemistry at the University of Houston, received a $1.8 million grant from the National Cancer Institute to design a therapeutic strategy to prevent progression of advanced drug-resistant hormone-receptor positive breast cancers, according…

UofL Health in Louisville, Ky., has partnered with Cancer and Blood Specialists of Louisville to open a third location of the academic health system's Brown Cancer Center. 

Researchers at Miami Cancer Institute are conducting several pediatric cancer studies focused on reducing dose to critical structures of the brain, minimizing toxicities from treatment and preserving neurocognitive function in survivors, Matthew Hall, MD, lead pediatric radiation oncologist at Miami…

A story about an advocacy group filing an ethics complaint against the University of Texas MD Anderson Cancer Center in Houston over undisclosed clinical trial results from 2005 was Becker's most-read oncology story in October.

Advertisement